EUCTR2004-004466-33-DEActive, not recruitingNot Applicable
doubleblind (observer blind), placebo-controlled, clinical-experimental study phase II in order to examine the local compatibility of Dr. Theiss Ringelblumen Salbe N by the duhring-chamber-test and in a open user trial - local compatibility test and open user trial with Dr. Theiss Ringelblumen Salbe
Conditions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Dr. Theiss Naturwaren GmbH
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •written informed consent written informed data protection healthy subjects with healthy normal skin conditions age more than 18 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •Volunteers who do not fulfill any of the above described criteria Volunteers who are pregnant or breast feeding Skin irritation or disease Skin dieseases or dermatological disorders Volunteeers with severe disorders Topical medication in the test areas Participation in an study in the last 4 weeks Consumption of alcohol or drugs
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Double blind (observer Blind) Placebo controlled, clinical-experimental Study of the Phase II for the examination of the local tolerance by Duhring-Chamber-Test as well as open user trial of the product Arnikamed Gelhealthy subjects with normal skin conditionsEUCTR2004-004511-39-DEDr. Theiss Naturwaren GmbH
Active, not recruiting
Not Applicable
Randomised, double blinded, placebo controlled, parallel group study toevaluate efficacy and safety of Depigoid® Grass / Birch Mix in patients withallergic rhinitis and/or rhinoconjunctivitis with or without mild intermittentasthma.Allergic rhinitis and/or rhinoconjunctivitis with or without mild intermittent asthma caused by clinical relevant sensitisation against grass pollen AND birch pollen.MedDRA version: 9.1Level: LLTClassification code 10039097Term: RhinoconjunctivitisMedDRA version: 9.1Level: LLTClassification code 10039095Term: Rhinitis seasonalEUCTR2008-002264-34-LTETI Pharma GmbH210
Active, not recruiting
Phase 1
Randomised, double blinded, placebo controlled, parallel group study to evaluate efficacy and safety of Depigoid® Grass / Birch Mix in patients with allergic rhinitis and/or rhinoconjunctivitis with or without mild intermittent asthma.Allergic rhinitis and/or rhinoconjunctivitis with or without mild intermittent asthma caused by clinical relevant sensitisation against grass pollen AND birch pollen.</MedDRA version: 9.1Level: LLTClassification code 10039097Term: RhinoconjunctivitisEUCTR2008-002264-34-PLETI Pharma GmbH210
Active, not recruiting
Not Applicable
Randomised, double blinded, placebo controlled, parallel group study toevaluate efficacy and safety of Depigoid® Grass / Birch Mix in patients withallergic rhinitis and/or rhinoconjunctivitis with or without mild intermittentasthma.Allergic rhinitis and/or rhinoconjunctivitis with or without mild intermittent asthma caused by clinical relevant sensitisation against grass pollen AND birch pollen.MedDRA version: 9.1Level: LLTClassification code 10039097Term: RhinoconjunctivitisMedDRA version: 9.1Level: LLTClassification code 10039095Term: Rhinitis seasonalEUCTR2008-002264-34-DEETI Pharma GmbH210
Active, not recruiting
Not Applicable
Randomised, double blinded, placebo controlled, parallel group study toevaluate efficacy and safety of Depigoid® Grass / Birch Mix in patients withallergic rhinitis and/or rhinoconjunctivitis with or without mild intermittentasthma.Allergic rhinitis and/or rhinoconjunctivitis with or without mild intermittent asthma caused by clinical relevant sensitisation against grass pollen AND birch pollen.MedDRA version: 9.1Level: LLTClassification code 10039097Term: RhinoconjunctivitisMedDRA version: 9.1Level: LLTClassification code 10039095Term: Rhinitis seasonalEUCTR2008-002264-34-BGETI Pharma GmbH210